Paper42792002PubMed
Vancomycin AUC24 Estimation for Children with Bayesian Forecasting and First-Order Equations to Update Dose Recommendations.
Kalliainen R and 4 others. Antibiotics (Basel), 2026.
Cite this record
ConductScience Library. Vancomycin AUC24 Estimation for Children with Bayesian Forecasting and First-Order Equations to Update Dose Recommendations. Papers, record 42792002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42792002
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Vancomycin AUC24 Estimation for Children with Bayesian Forecasting and First-Order Equations to Update Dose Recommendations.
- Journal
- Antibiotics (Basel)
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-09-29
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Department of Pediatrics and Department of Anesthesiology and Intensive Care, Kuopio University Hospital | PubMed |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39935555 | Vancomycin Area Under the Curve to Minimum Inhibitory Concentration Ratio for Treatment Effectiveness in Pediatric and Neonatal Staphylococcal Infections: A Systematic Review. | J Pediatr Pharmacol Ther | 2025 | https://conductscience.org/library/papers/39935555 | PubMed |
| 2 | 34002357 | Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review. | Clin Pharmacokinet | 2021 | https://conductscience.org/library/papers/34002357 | PubMed |
| 3 | 23340565 | Improved vancomycin dosing in children using area under the curve exposure. | Pediatr Infect Dis J | 2013 | https://conductscience.org/library/papers/23340565 | PubMed |
| 4 | 950590 | Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients. | J Pharmacokinet Biopharm | 1976 | https://conductscience.org/library/papers/950590 | PubMed |
| 5 | 24452067 | Vancomycin monitoring in children using bayesian estimation. | Ther Drug Monit | 2014 | https://conductscience.org/library/papers/24452067 | PubMed |
| 6 | 26582878 | Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children. | J Pediatric Infect Dis Soc | 2015 | https://conductscience.org/library/papers/26582878 | PubMed |
| 7 | 30656565 | Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations. | Clin Pharmacokinet | 2019 | https://conductscience.org/library/papers/30656565 | PubMed |
| 8 | 33068298 | Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin. | Clin Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33068298 | PubMed |
| 9 | 39438393 | Comparison of Vancomycin AUC24 Calculation Methods for Neonates and Infants. | Eur J Drug Metab Pharmacokinet | 2024 | https://conductscience.org/library/papers/39438393 | PubMed |
| 10 | 34671937 | An Update on Population Pharmacokinetic Analyses of Vancomycin, Part II: In Pediatric Patients. | Clin Pharmacokinet | 2022 | https://conductscience.org/library/papers/34671937 | PubMed |
| 11 | 18703997 | Impact of standardization of creatinine methodology on the assessment of glomerular filtration rate in children. | Pediatr Res | 2009 | https://conductscience.org/library/papers/18703997 | PubMed |
| 12 | 26378371 | Evaluation of Target Attainment of Vancomycin Area Under the Curve in Children With Methicillin-Resistant Staphylococcus Aureus Bacteremia. | Ther Drug Monit | 2015 | https://conductscience.org/library/papers/26378371 | PubMed |
| 13 | 40715988 | A Large Cohort Study to Identify Risk Factors of Acute Kidney Injury in Pediatric Patients Undergoing Intravenous Vancomycin Therapy. | Pharmacotherapy | 2025 | https://conductscience.org/library/papers/40715988 | PubMed |
| 14 | 8574501 | Adaptive control of drug dosage regimens using maximum a posteriori probability Bayesian fitting. | Int J Clin Pharmacol Ther | 1995 | https://conductscience.org/library/papers/8574501 | PubMed |
| 15 | 36222533 | Association between Vancomycin Pharmacokinetic Parameters and Clinical and Microbiological Efficacy in a Cohort of Neonatal Patients. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/36222533 | PubMed |
| 16 | 34145165 | Implementation of Vancomycin Therapeutic Monitoring Guidelines: Focus on Bayesian Estimation Tools in Neonatal and Pediatric Patients. | Ther Drug Monit | 2022 | https://conductscience.org/library/papers/34145165 | PubMed |
| 17 | 38533999 | Vancomycin AUC0-24 estimation using first-order pharmacokinetic methods in pediatric patients. | Pharmacotherapy | 2024 | https://conductscience.org/library/papers/38533999 | PubMed |
| 18 | 30833429 | Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/30833429 | PubMed |
| 19 | 42194175 | Vancomycin Therapeutic Drug Monitoring, Clinical Outcomes and Population Pharmacokinetic Model Evaluation in Neonates. | Children (Basel) | 2026 | https://conductscience.org/library/papers/42194175 | PubMed |
| 20 | 32191793 | Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. | Am J Health Syst Pharm | 2020 | https://conductscience.org/library/papers/32191793 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42792002
GET https://conductscience.org/api/papers/v1/42792002/references?page=2